Ayala Pharmaceuticals Inc
(ADXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2009 | 07-2009 | 04-2009 | 01-2009 | 10-2008 | |
| Sales | 0 | -5 | 0 | 0 | 0 |
| Gross Profit | N/A | -5 | N/A | N/A | N/A |
| Operating Expenses | 0 | 1,462 | 772 | 725 | 0 |
| Operating Income | N/A | -1,468 | -772 | -725 | N/A |
| Interest Expense | 0 | 375 | 21 | 15 | 0 |
| Other Income | 0 | 2,014 | 0 | 0 | 0 |
| Pre-tax Income | 0 | 172 | -793 | -740 | 0 |
| Income Tax | N/A | N/A | N/A | -922 | N/A |
| Net Income Continuous | N/A | 172 | -793 | 182 | N/A |
| Net Income | $N/A | $172 | $-793 | $182 | $N/A |
| EPS Basic Total Ops | N/A | 0.00 | -0.01 | 0.00 | N/A |
| EPS Basic Continuous Ops | N/A | 0.00 | -0.01 | 0.00 | N/A |
| EPS Diluted Total Ops | N/A | 0.00 | -0.01 | 0.00 | N/A |
| EPS Diluted Continuous Ops | N/A | 0.00 | -0.01 | 0.00 | N/A |
| EBITDA(a) | $N/A | $-1,402 | $-745 | $-698 | $N/A |